‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients
(By Meghana Keshavan for ST A T) V ickie Moored can walk again. Her words don’t slur, her vision isn’t
Read More
Part D/Prescription Drugs
The long-delayed 340B final rule is out
The rule for the 340B drug discount program, which would set price ceilings and monetary penalties, will begin of next
Read MoreMedicare Part D costs and deductibles for 2019
Do you know what is covered under Medicare Part D? Did you know that private companies that offer Part D
Read MoreDemocrats Taking Key Leadership Jobs Have Pocketed Millions From Pharma
(By Emmarie Huetteman for Kaiser Health News) Three of the lawmakers who will lead the House next year as Congress
Read MoreGetting out of the Medicare drug doughnut hole faster
The new law that bans “gag clauses”, which had prevented pharmacist in some states from letting customers know about a
Read MoreFDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower
(By Ed Silverman for ST A T) F ile this under “When is a bargain not really a bargain?” Three
Read MoreChronically Ill, Traumatically Billed: The $123,000 Medicine For MS
(By Jay Hancock for Kaiser Health News) Shereese Hickson’s multiple sclerosis was flaring again. Spasms in her legs and other
Read MoreOne-third of Americans didn’t fill at least one of their prescription drugs due to cost
A recent survey conducted by GoodRx found one-third of Americans didn’t fill at least one of their prescriptions over the
Read MoreHow FEHB works with Medicare
Do you have a Federal Employees Health Benefits (FEHB) Plan? Are you wondering if you should add Medicare as part
Read MoreTrump administration proposes letting private Medicare plans exclude new types of drugs
(By Nicholas Florko for ST A T) W ASHINGTON — The Trump administration wants to give private Medicare plans the
Read More